PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $296,000 | +3.1% | 93,256 | -5.5% | 0.00% | -100.0% |
Q2 2020 | $287,000 | +567.4% | 98,634 | +654.5% | 0.00% | – |
Q4 2019 | $43,000 | +59.3% | 13,072 | +4.9% | 0.00% | – |
Q3 2019 | $27,000 | -28.9% | 12,456 | +22.4% | 0.00% | – |
Q1 2019 | $38,000 | -92.7% | 10,175 | -95.5% | 0.00% | -100.0% |
Q1 2017 | $520,000 | -2.1% | 223,634 | -10.8% | 0.00% | 0.0% |
Q4 2016 | $531,000 | -28.7% | 250,691 | +12.5% | 0.00% | -50.0% |
Q3 2016 | $745,000 | +6.4% | 222,831 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $700,000 | -5.0% | 222,831 | +0.8% | 0.00% | 0.0% |
Q1 2016 | $737,000 | -6.2% | 221,115 | +0.3% | 0.00% | 0.0% |
Q4 2015 | $786,000 | -30.6% | 220,562 | -1.8% | 0.00% | -33.3% |
Q3 2015 | $1,132,000 | -55.4% | 224,578 | -42.8% | 0.00% | -40.0% |
Q2 2015 | $2,538,000 | +23.3% | 392,732 | +34.1% | 0.01% | +25.0% |
Q1 2015 | $2,059,000 | – | 292,776 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |